{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:39:33Z","timestamp":1789699173455,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10072-022-06258-7","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:02:56Z","timestamp":1658116976000},"page":"5899-5908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and internal validation of a prognostic model for 15-year risk of Alzheimer dementia in primary care patients"],"prefix":"10.1007","volume":"43","author":[{"given":"Giulia","family":"Grande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide L.","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Guglielmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana","family":"Taddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano F.","family":"Cappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-9128","authenticated-orcid":false,"given":"Francesco","family":"Lapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"6258_CR1","unstructured":"World Health Organization (\u200e2015) World report on ageing and health. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/186463"},{"key":"6258_CR2","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9. Erratum in: Lancet. 2020 Nov 14;396(10262):1562.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"6258_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M et al (2020) The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 19:255\u2013265. https:\/\/doi.org\/10.1016\/S1474-4422(19)30411-9","journal-title":"Lancet Neurol"},{"key":"6258_CR4","unstructured":"World Health Organization (2015) Global action against dementia. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/179537\/9789241509114_eng.pdf"},{"key":"6258_CR5","unstructured":"Alzheimer\u2019s Disease International (2015) The global impact of dementia: An analysis of prevalence, cost and trends. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2015\/"},{"key":"6258_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al (2016) Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455\u2013532","journal-title":"Lancet Neurol"},{"key":"6258_CR7","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","volume":"390","author":"RM Anderson","year":"2017","unstructured":"Anderson RM, Hadjichrysanthou C, Evans S, Wong MM (2017) Why do so many clinical trials of therapies for Alzheimer\u2019s disease fail? Lancet 390:2327\u20132329","journal-title":"Lancet"},{"key":"6258_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","volume":"5","author":"J Cummings","year":"2019","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2019) Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimers Dement (N Y) 5:272\u2013293","journal-title":"Alzheimers Dement (N Y)"},{"key":"6258_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413\u2013446","journal-title":"Lancet"},{"key":"6258_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-150692","volume":"49","author":"B Dubois","year":"2016","unstructured":"Dubois B, Padovani A, Scheltens P, Rossi A, Dell\u2019Agnello G (2016) Timely diagnosis for Alzheimer\u2019s disease: a literature review on benefits and challenges. J Alzheimers Dis 49:617\u2013631","journal-title":"J Alzheimers Dis"},{"key":"6258_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, O\u2019Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639\u2013652","journal-title":"Nat Rev Neurol"},{"key":"6258_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/(SICI)1099-1166(199611)11:11<937::AID-GPS540>3.0.CO;2-0","volume":"11","author":"MG Downs","year":"1996","unstructured":"Downs MG (1996) The role of general practice and the primary care team in dementia diagnosis and management. Int J Ger Psychiatry 11:937\u2013942","journal-title":"Int J Ger Psychiatry"},{"issue":"7","key":"6258_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/ene.13313","volume":"24","author":"G Grande","year":"2017","unstructured":"Grande G, Tramacere I, Vetrano DL, Clerici F, Pomati S, Mariani C, Filippini G, REMIND Study Group (Rete Milanese Integrata per le Demenze) (2017) Role of anticholinergic burden in primary care patients with first cognitive complaints. Eur J Neurol. 24(7):950\u2013955. https:\/\/doi.org\/10.1111\/ene.13313","journal-title":"Eur J Neurol."},{"issue":"4","key":"6258_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000509379","volume":"49","author":"G Grande","year":"2020","unstructured":"Grande G, Vetrano DL, Mazzoleni F, Lovato V, Pata M, Cricelli C, Lapi F (2020) Detection and prediction of incident Alzheimer dementia over a 10-year or longer medical history: a population-based study in primary care. Dement Geriatr Cogn Disord 49(4):384\u2013389. https:\/\/doi.org\/10.1159\/000509379","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"6258_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194735","volume":"13","author":"E Ford","year":"2018","unstructured":"Ford E, Greenslade N, Paudyal P, Bremner S, Smith HE, Banerjee S, Sadhwani S, Rooney P, Oliver S, Cassell J (2018) Predicting dementia from primary care records: a systematic review and meta-analysis. PLoS One 13(3):e0194735. https:\/\/doi.org\/10.1371\/journal.pone.0194735","journal-title":"PLoS One"},{"key":"6258_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3731","volume":"371","author":"AK Clift","year":"2020","unstructured":"Clift AK et al (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 371:m3731","journal-title":"BMJ"},{"issue":"7","key":"6258_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/aje\/kwr374","volume":"175","author":"A Ganna","year":"2012","unstructured":"Ganna A, Reilly M, De Faire U, Pedersen N, Magnusson P, Ingelsson E (2012) Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol 175(7):715\u2013724. https:\/\/doi.org\/10.1093\/aje\/kwr374","journal-title":"Am J Epidemiol"},{"key":"6258_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jbi.2014.12.016","volume":"54","author":"K Van Hoorde","year":"2015","unstructured":"Van Hoorde K, Van Huffel S, Timmerman D, Bourne T, Van Calster B (2015) A spline-based tool to assess and visualize the calibration of multiclass risk predictions. J Biomed Inform 54:283\u2013293. https:\/\/doi.org\/10.1016\/j.jbi.2014.12.016","journal-title":"J Biomed Inform"},{"key":"6258_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jclinepi.2015.12.005","volume":"74","author":"B Van Calster","year":"2016","unstructured":"Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW (2016) A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol 74:167\u2013176. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.12.005","journal-title":"J Clin Epidemiol"},{"key":"6258_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/01621459.1957.10501411","volume":"52","author":"DR Cox","year":"1957","unstructured":"Cox DR (1957) Note on Grouping. J Am Stat Assoc 52:543\u2013547. https:\/\/doi.org\/10.1080\/01621459.1957.10501411","journal-title":"J Am Stat Assoc"},{"key":"6258_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2261-7-38","volume":"7","author":"JA Delaney","year":"2007","unstructured":"Delaney JA et al (2007) Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord 7:38","journal-title":"BMC Cardiovasc Disord"},{"key":"6258_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735\u2013741","journal-title":"Lancet Neurol"},{"key":"6258_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrneurol.2010.54","volume":"6","author":"BC Stephan","year":"2010","unstructured":"Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C (2010) Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol 6:318\u2013326","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"6258_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/JAD-200445","volume":"77","author":"T M\u00fcller","year":"2020","unstructured":"M\u00fcller T, Payton NM, Kalpouzos G, Jessen F, Grande G, B\u00e4ckman L, Laukka EJ (2020) Cognitive, genetic, brain volume, and diffusion tensor imaging markers as early indicators of dementia. J Alzheimers Dis 77(4):1443\u20131453. https:\/\/doi.org\/10.3233\/JAD-200445","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"6258_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/alz.12002","volume":"16","author":"G Grande","year":"2020","unstructured":"Grande G, Rizzuto D, Vetrano DL, Marseglia A, Vanacore N, Laukka JE, Welmer AK, Fratiglioni L (2020) Cognitive and physical markers of prodromal dementia: a 12-year-long population study. Alzheimers Dement 16(1):153\u2013161","journal-title":"Alzheimers Dement"},{"key":"6258_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4181","volume":"344","author":"GS Collins","year":"2012","unstructured":"Collins GS, Altman D (2012) Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 344:e4181","journal-title":"BMJ"},{"issue":"346","key":"6258_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2573","volume":"2","author":"J Hippisley-Cox","year":"2013","unstructured":"Hippisley-Cox J, Coupland C, Brindle P (2013) Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ 2(346):f2573. https:\/\/doi.org\/10.1136\/bmj.f2573","journal-title":"BMJ"},{"key":"6258_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5019","volume":"359","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C (2017) Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study. BMJ 359:j5019. https:\/\/doi.org\/10.1136\/bmj.j5019","journal-title":"BMJ"},{"key":"6258_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12916-016-0549-y","volume":"14","author":"K Walters","year":"2016","unstructured":"Walters K, Hardoon S, Petersen I et al (2016) Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med 14:6","journal-title":"BMC Med"},{"issue":"1","key":"6258_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039248","volume":"11","author":"E Ford","year":"2021","unstructured":"Ford E, Sheppard J, Oliver S, Rooney P, Banerjee S, Cassell JA (2021) Automated detection of patients with dementia whose symptoms have been identified in primary care but have no formal diagnosis: a retrospective case-control study using electronic primary care records. BMJ Open 11(1):e039248. https:\/\/doi.org\/10.1136\/bmjopen-2020-039248","journal-title":"BMJ Open"},{"issue":"3","key":"6258_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183\u2013194. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01388.x","journal-title":"J Intern Med"},{"key":"6258_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/alz.12163","volume":"16","author":"F Jessen","year":"2020","unstructured":"Jessen F, Kleineidam L, Wolfsgruber S, Bickel H, Brettschneider C, Fuchs A et al (2020) Prediction of dementia of Alzheimer type by different types of subjective cognitive decline. Alzheimers Dement 16:1745\u20131749. https:\/\/doi.org\/10.1002\/alz.12163","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6258_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1212\/WNL.0b013e3181e62124","volume":"75","author":"VM Dotson","year":"2010","unstructured":"Dotson VM, Beydoun MA, Zonderman AB (2010 Jul 6) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75(1):27\u201334","journal-title":"Neurology"},{"issue":"2","key":"6258_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1037\/a0015713","volume":"24","author":"JA Brommelhoff","year":"2009","unstructured":"Brommelhoff JA, Gatz M, Johansson B, McArdle JJ, Fratiglioni L, Pedersen NL (2009) Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychol Aging 24(2):373\u2013384","journal-title":"Psychol Aging"},{"issue":"7","key":"6258_CR35","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","volume":"74","author":"A Singh-Manoux","year":"2017","unstructured":"Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivimaki M et al (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiat 74(7):712\u2013718","journal-title":"JAMA Psychiat"},{"issue":"6","key":"6258_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","volume":"24","author":"D Enache","year":"2011","unstructured":"Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24(6):461\u2013472","journal-title":"Curr Opin Psychiatry"},{"key":"6258_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/PSY.0b013e3181a6177c","volume":"71","author":"J Gallacher","year":"2009","unstructured":"Gallacher J, Bayer A, Fish M et al (2009) Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 71:659\u2013666","journal-title":"Psychosom Med"},{"issue":"1","key":"6258_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/fampra\/cms044","volume":"30","author":"C Burton","year":"2013","unstructured":"Burton C, Campbell P, Jordan K, Strauss V, Mallen C (2013) The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care. Fam Pract 30(1):25\u201330. https:\/\/doi.org\/10.1093\/fampra\/cms044","journal-title":"Fam Pract"},{"issue":"24","key":"6258_CR39","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1212\/01.wnl.0000313933.17796.f6","volume":"70","author":"CA Szekely","year":"2008","unstructured":"Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM et al (2008) No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 70(24):2291\u20132298","journal-title":"Neurology"},{"key":"6258_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505\u2013522","journal-title":"Nat Rev Cardiol"},{"key":"6258_CR41","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822\u20131832","journal-title":"Nat Med"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06258-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:08:56Z","timestamp":1663200536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06258-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6258"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06258-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to a by-law on the classification and implementation of observational drug-related research, as issued by the Italian Medicines Agency, the present study does not require approval by an ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"FL, EM, EB and IC provided consultancies in protocol preparation for epidemiological studies and data analyses for Roche and Abbvie; DT and CC provided clinical consultancies for Roche, Abbvie and Viatris; VL and LG are employees of Roche S.p.A., Monza, Italy;\u00a0the other co-authors have no conflict of interest to diclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}